Respiratory Infections News

Moderna has announced that its COVID-19 vaccine was 93% effective, with “durable” efficacy lasting at least 6 months after administration of the second dose.

Roughly 5% of children aged 5 to 17 years experienced COVID-19 symptoms for at least 28 days, and almost 2% were still experiencing them after 56 days, according to the results of a study in the United Kingdom.

Therapeutic anticoagulation with heparin increased the likelihood of survival among noncritically ill patients who were hospitalized with COVID-19, according to a new study in The New England Journal of Medicine.

A single subcutaneous dose of Regeneron’s antibody cocktail prevents symptomatic COVID-19 and reduces the incidence of asymptomatic SARS-CoV-2 infection, according to results from a study published today in The New England Journal of Medicine.

WHO has called for a moratorium on COVID-19 vaccine boosters until at least the end of September to enable lower income countries to raise their vaccination rates.

The AMA has announced the CPT codes for a third dose of the Pfizer-BioNTech COVID-19 vaccine if one is authorized or approved by the FDA.

Around 9% of health care workers at two New York hospitals said they were unwilling to provide care to patients with COVID-19 early in the pandemic — a much lower percentage than during epidemics of HIV and Ebola, researchers reported.

The AAP issued interim guidance on pediatric follow-up care for children who have had COVID-19, including recommendations for children with long COVID, a syndrome that is less common among kids than adults.

A retracted New England Journal of Medicine study on the link between CVD, renin-angiotensin–aldosterone system inhibitor therapy and COVID-19 outcomes continues to be “widely cited” in medical literature, researchers wrote.

Among nearly 460,000 people surveyed in the United States earlier this year, more than 10% said they would “probably not” get a COVID-19 vaccine and more than 8% said they would “definitely not,” researchers reported.